SEC Form D · Amendment · filed February 1, 2021
Ablative Solutions, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Andrew R. Tochterman · Wakefield, MADirectorDavid R. Fischell · Wakefield, MADirectorJohn R. Kerschen · Wakefield, MADirectorPaul R. Buckman · Wakefield, MADirectorMichael R. Fulton · Wakefield, MADirectorGeoff R. Pardo · Wakefield, MADirectorKate R. Rumrill · Wakefield, MAExec · DirectorLisa R. Mastromattei · Wakefield, MAExecDebra D. Flickinger · Los Angeles, CAExec · DirectorPierre Bertrand · Coppell, TXExecLydia L. Gavalls · Conshohocken, PADirectorJon Mosle Iii · Dallas, TXDirectorDanny Perales · Coppell, TXDirectorJarkko Matilainen · Helsinki, H9DirectorJon Mosle Iii · Dallas, TXDirectorThomas Parsons Jr · Grand Cayman, Cayman IslandsDirectorJames Tananbaum · Larkspur, CADirectorLorien Gabel · New York, NYDirectorJames Parillo · New York, NYDirectorYoungmok Yun · Austin, TXDirectorRobert M. Pavey · Wilton, CTDirectorMattia F. Caprioli · NEW YORK, NYExec · DirectorPhilip F. Kim · NEW YORK, NYExecWebster F. Chua · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗